Search Within

Aliaksandra Samoila

Formats
  1. Meeting Abstract (11)
  2. Journal Article (10)
  3. Research Letter (2)
Groups
  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. GSK Faculty (16)
  4. Human Oncology and Pathogenesis Program (15)
  5. Breast Medicine Service (12)
  6. Department of Pathology and Laboratory Medicine (10)

More Groups

People
  1. Daoqi You (10)
  2. Michael Berger (9)
  3. Sarat Chandarlapaty (8)
  4. Jose Baselga (7)
  5. Sadan Duygu Selcuklu (7)
  6. Agnes Viale (6)

More People

Years
  1. 2021 (2)
  2. 2020 (2)
  3. 2019 (3)
  4. 2018 (1)
  5. 2017 (3)
  6. 2016 (6)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (3)
  3. JCO Precision Oncology (2)
  4. Journal of Molecular Diagnostics (2)
  5. British Journal of Cancer (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (4)
  4. Elsevier Science, Inc. (3)
  5. Amer Assoc Clinical Chemistry (1)
  6. American Medical Association (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2-advanced breast cancer: Results from BOLERO-2
    Journal Article

    Moynahan, M. E.; Chen, D.; He, W.; Sung, P.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Ringeisen, F.; Hortobagyi, G. N.; more...
    British Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363)
    Meeting Abstract

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, S. D.; You, D.; Samoila, A.; Schiavon, G.; Li, B. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of PIK3CA mutations in cell-ree DNA (cfDNA) and efficacy of everolimus (EVE in metastatic breast cancer: Results from BOLERO-2
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Ringeisen, F. P.; Hortobagyi, G. N.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer: A secondary analysis of the BOLERO-2 clinical trial
    Journal Article

    Chandarlapaty, S.; Chen, D.; He, W.; Sung, P.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Voi, M.; Gnant, M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma
    Meeting Abstract

    Lowery, M. A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
    Journal Article

    Danila, D. C.; Samoila, A.; Patel, C.; Schreiber, N.; Herkal, A.; Anand, A.; Bastos, D.; Heller, G.; Fleisher, M.; Scher, H. I.
    The Cancer Journal (2016)

    Fulltext@MSK | Save
  • cfDNA analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 mutations: Exploratory analysis for prognostic and predictive correlation of mutations reveals different efficacy outcomes of endocrine therapy-based regimens
    Meeting Abstract

    Chandarlapaty, S.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Voi, M.; Gnant, M.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Method development and validation for clinical cfDNA extraction from blood
    Meeting Abstract

    Samoila, A.; Patel, C.; Kothadia, K. J.; You, D.; Lemetre, C.; Scacalossi, D. M.; Babady, N. E.; Peerschke, E. I. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N. A.; Anand, A.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save